Table Filtering
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlyCOVID
GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.
Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438
A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.
| Source | Last Updated |
|---|---|
| PSICQUIC | March 30, 2022 |
| Antibody | Patient | Onset (days) | Symptom | GlyTouCan ID ▼ | Arbitrary Fluorescence Units (AFU) |
|---|---|---|---|---|---|
| IgM | Patient 3 | 11 | mild |
G17390SF
|
129 |
| IgM | Patient 3 | 4 | mild |
G17390SF
|
94 |
| IgA | Patient 4 | 12 | mild |
G17390SF
|
991 |
| IgG | Patient 4 | 12 | mild |
G17390SF
|
235 |
| IgM | Patient 4 | 12 | mild |
G17390SF
|
1796 |
| IgA | Patient 1 | 10 | moderate |
G17266GE
|
348 |
| IgA | Patient 1 | 22 | moderate |
G17266GE
|
350 |
| IgA | Patient 1 | 6 | moderate |
G17266GE
|
338 |
| IgG | Patient 1 | 10 | moderate |
G17266GE
|
22 |
| IgG | Patient 1 | 22 | moderate |
G17266GE
|
23 |
| IgG | Patient 1 | 6 | moderate |
G17266GE
|
25 |
| IgM | Patient 1 | 10 | moderate |
G17266GE
|
36 |
| IgM | Patient 1 | 22 | moderate |
G17266GE
|
38 |
| IgM | Patient 1 | 6 | moderate |
G17266GE
|
30 |
| IgA | Patient 2 | 15 | mild |
G17266GE
|
352 |
| IgA | Patient 2 | 24 | mild |
G17266GE
|
365 |
| IgG | Patient 2 | 15 | mild |
G17266GE
|
41 |
| IgG | Patient 2 | 24 | mild |
G17266GE
|
51 |
| IgM | Patient 2 | 15 | mild |
G17266GE
|
146 |
| IgM | Patient 2 | 24 | mild |
G17266GE
|
227 |
| IgA | Patient 2 | 3 | mild |
G17266GE
|
336 |
| IgG | Patient 2 | 3 | mild |
G17266GE
|
48 |
| IgM | Patient 2 | 3 | mild |
G17266GE
|
199 |
| IgA | Patient 3 | -180 | mild |
G17266GE
|
285 |
| IgA | Patient 3 | 11 | mild |
G17266GE
|
476 |
